|
Read more ›› |
By: PR Newswire Association LLC. - 16 Apr 2024
|
Related companies:
EmVenio Research |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 16 Apr 2024
|
Related companies:
Viatris Inc. |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 16 Apr 2024
|
Related companies:
Amgen Inc. |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 16 Apr 2024
|
|
|
Read more ›› |
By: PR Newswire Association LLC. - 16 Apr 2024
|
|
|
Read more ›› |
By: PR Newswire Association LLC. - 16 Apr 2024
|
Related companies:
WELL Health Technologies Corp. |
|
|
Read more ›› |
By: GlobeNewswire - 16 Apr 2024
|
Related companies:
Genmab A/S |
|
|
Read more ›› |
By: GlobeNewswire - 16 Apr 2024
|
Related companies:
Cullinan Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 16 Apr 2024
|
Related companies:
Ocular Therapeutix, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 16 Apr 2024
|
Related companies:
Kincell Bio |
|
|
Read more ›› |
By: GlobeNewswire - 16 Apr 2024
|
Related companies:
Foghorn Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 16 Apr 2024
|
Related companies:
Cullinan Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 16 Apr 2024
|
Related companies:
AxoGen, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 16 Apr 2024
|
Related companies:
EyePoint Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 16 Apr 2024
|
Related companies:
Treace Medical Concepts, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 16 Apr 2024
|
Related companies:
Voyager Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 16 Apr 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 16 Apr 2024
|
Related companies:
Intra-Cellular Therapies, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 16 Apr 2024
|
Related companies:
Clearside Biomedical, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 16 Apr 2024
|
Related companies:
Arch Biopartners, Inc. |
|